AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2020
Dec 1, 2020
29755_dirs_2020-12-01_310ecb92-e798-47d0-ad43-4d67578ee1c3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2020-11-27
Reporting Person: RICHMOND TIMOTHY J. (EVP, Chief HR Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-11-27 | Common Stock, $0.01 par value | M | 51990 | $51.42 | Acquired | 51990 | Direct |
| 2020-11-27 | Common Stock, $0.01 par value | S | 51990 | $105 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-11-27 | Option (Right to buy) | $51.42 | M | 51990 | Disposed | 2024-02-19 | Common stock (51990) | Direct |
Footnotes
F1: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4